471 related articles for article (PubMed ID: 15596830)
61. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.
Hauck B; Zhao W; High K; Xiao W
J Virol; 2004 Dec; 78(24):13678-86. PubMed ID: 15564477
[TBL] [Abstract][Full Text] [Related]
62. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.
Wang Y; Ling C; Song L; Wang L; Aslanidi GV; Tan M; Ling C; Srivastava A
Hum Gene Ther Methods; 2012 Aug; 23(4):225-33. PubMed ID: 22966785
[TBL] [Abstract][Full Text] [Related]
63. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.
Srivastava CH; Samulski RJ; Lu L; Larsen SH; Srivastava A
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8078-82. PubMed ID: 2554300
[TBL] [Abstract][Full Text] [Related]
64. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.
Recchia A; Parks RJ; Lamartina S; Toniatti C; Pieroni L; Palombo F; Ciliberto G; Graham FL; Cortese R; La Monica N; Colloca S
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2615-20. PubMed ID: 10077559
[TBL] [Abstract][Full Text] [Related]
65. Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo.
Nakai H; Fuess S; Storm TA; Meuse LA; Kay MA
Mol Ther; 2003 Jan; 7(1):112-21. PubMed ID: 12573624
[TBL] [Abstract][Full Text] [Related]
66. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A.
Dyka FM; Boye SL; Chiodo VA; Hauswirth WW; Boye SE
Hum Gene Ther Methods; 2014 Apr; 25(2):166-77. PubMed ID: 24568220
[TBL] [Abstract][Full Text] [Related]
67. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.
Palombo F; Monciotti A; Recchia A; Cortese R; Ciliberto G; La Monica N
J Virol; 1998 Jun; 72(6):5025-34. PubMed ID: 9573272
[TBL] [Abstract][Full Text] [Related]
68. AAV as a viral vector for human gene therapy. Generation of recombinant virus.
Rolling F; Samulski RJ
Mol Biotechnol; 1995 Feb; 3(1):9-15. PubMed ID: 7606507
[TBL] [Abstract][Full Text] [Related]
69. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.
Reich SJ; Auricchio A; Hildinger M; Glover E; Maguire AM; Wilson JM; Bennett J
Hum Gene Ther; 2003 Jan; 14(1):37-44. PubMed ID: 12573057
[TBL] [Abstract][Full Text] [Related]
70. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner.
Ghosh A; Yue Y; Lai Y; Duan D
Mol Ther; 2008 Jan; 16(1):124-30. PubMed ID: 17984978
[TBL] [Abstract][Full Text] [Related]
71. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.
Costantini LC; Jacoby DR; Wang S; Fraefel C; Breakefield XO; Isacson O
Hum Gene Ther; 1999 Oct; 10(15):2481-94. PubMed ID: 10543613
[TBL] [Abstract][Full Text] [Related]
72. ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing.
Breton C; Clark PM; Wang L; Greig JA; Wilson JM
BMC Genomics; 2020 Mar; 21(1):239. PubMed ID: 32183699
[TBL] [Abstract][Full Text] [Related]
73. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
74. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease.
Trapani I; Toriello E; de Simone S; Colella P; Iodice C; Polishchuk EV; Sommella A; Colecchi L; Rossi S; Simonelli F; Giunti M; Bacci ML; Polishchuk RS; Auricchio A
Hum Mol Genet; 2015 Dec; 24(23):6811-25. PubMed ID: 26420842
[TBL] [Abstract][Full Text] [Related]
75. Deletion of the B-B' and C-C' regions of inverted terminal repeats reduces rAAV productivity but increases transgene expression.
Zhou Q; Tian W; Liu C; Lian Z; Dong X; Wu X
Sci Rep; 2017 Jul; 7(1):5432. PubMed ID: 28710345
[TBL] [Abstract][Full Text] [Related]
76. Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair.
Hirsch ML; Green L; Porteus MH; Samulski RJ
Gene Ther; 2010 Sep; 17(9):1175-80. PubMed ID: 20463753
[TBL] [Abstract][Full Text] [Related]
77. Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.
Sandalon Z; Gnatenko DV; Bahou WF; Hearing P
J Virol; 2000 Nov; 74(22):10381-9. PubMed ID: 11044082
[TBL] [Abstract][Full Text] [Related]
78. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells.
Halbert CL; Alexander IE; Wolgamot GM; Miller AD
J Virol; 1995 Mar; 69(3):1473-9. PubMed ID: 7853479
[TBL] [Abstract][Full Text] [Related]
79. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.
Yan Z; Zhang Y; Duan D; Engelhardt JF
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6716-21. PubMed ID: 10841568
[TBL] [Abstract][Full Text] [Related]
80. A novel terminal resolution-like site in the adeno-associated virus type 2 genome.
Wang XS; Srivastava A
J Virol; 1997 Feb; 71(2):1140-6. PubMed ID: 8995635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
